Literature DB >> 10381672

Angiogenic factors in human proliferative sickle cell retinopathy.

J Cao1, M K Mathews, D S McLeod, C Merges, L M Hjelmeland, G A Lutty.   

Abstract

BACKGROUND/AIMS: Preretinal neovascular formations called sea fans develop at the border of non-perfused peripheral retina in sickle cell retinopathy. Angiogenic factors which could contribute to their development, however, have not been examined previously. The objective of this study was to determine immunohistochemically if vascular endothelial growth factor (VEGF) or basic fibroblast growth factor (bFGF) were associated with sea fan formations.
METHODS: Immunohistochemistry on cryosections was used to localise bFGF, VEGF, heparan sulphate proteoglycan, human serum albumin, collagens IV and II, and von Willebrand factor in tissue from five sickle cell and one control subject.
RESULTS: The greatest immunoreactivity for VEGF and bFGF was in the feeder and preretinal vessels of sea fans (p<0.01). The most prominent reaction product was localised to vascular endothelial cells. In retinal vessels, VEGF and bFGF immunoreactivities were greater in sickle cell subjects (both proliferative and non-proliferative) than in the control subject (p<0.01 and p<0.02 respectively). In the sickle cell retina, no angiogenic factor immunoreactivity was detected in non-perfused periphery and there was no significant difference in bFGF or VEGF immunoreactivity between perfused retina and the border of perfused and non-perfused areas.
CONCLUSION: Our results demonstrate for the first time that VEGF and bFGF are associated with sea fan formations in sickle cell retinopathy. Both factors may function in an autocrine manner because immunoreactivity for these factors was greater within the neovascularisation than in adjacent retina.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10381672      PMCID: PMC1723129          DOI: 10.1136/bjo.83.7.838

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  29 in total

1.  Localization of vascular endothelial growth factor in human retina and choroid.

Authors:  G A Lutty; D S McLeod; C Merges; A Diggs; J Plouét
Journal:  Arch Ophthalmol       Date:  1996-08

2.  Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway.

Authors:  V Simorre-Pinatel; M Guerrin; P Chollet; M Penary; S Clamens; F Malecaze; J Plouet
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-08       Impact factor: 4.799

3.  Basement membrane abnormalities in human eyes with diabetic retinopathy.

Authors:  A V Ljubimov; R E Burgeson; R J Butkowski; J R Couchman; L Zardi; Y Ninomiya; Y Sado; Z S Huang; A B Nesburn; M C Kenney
Journal:  J Histochem Cytochem       Date:  1996-12       Impact factor: 2.479

4.  Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.

Authors:  R H Amin; R N Frank; A Kennedy; D Eliott; J E Puklin; G W Abrams
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-01       Impact factor: 4.799

5.  Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid.

Authors:  D S McLeod; D J Lefer; C Merges; G A Lutty
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

6.  Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis.

Authors:  D T Shima; A Gougos; J W Miller; M Tolentino; G Robinson; A P Adamis; P A D'Amore
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-06       Impact factor: 4.799

7.  Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen.

Authors:  D T Shima; A P Adamis; N Ferrara; K T Yeo; T K Yeo; R Allende; J Folkman; P A D'Amore
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

8.  Hypoxia and platelet-derived growth factor-BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells.

Authors:  G T Stavri; Y Hong; I C Zachary; G Breier; P A Baskerville; S Ylä-Herttuala; W Risau; J F Martin; J D Erusalimsky
Journal:  FEBS Lett       Date:  1995-01-30       Impact factor: 4.124

9.  Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability.

Authors:  D T Shima; U Deutsch; P A D'Amore
Journal:  FEBS Lett       Date:  1995-08-21       Impact factor: 4.124

10.  Hypoxic regulation of vascular endothelial growth factor in retinal cells.

Authors:  L P Aiello; J M Northrup; B A Keyt; H Takagi; M A Iwamoto
Journal:  Arch Ophthalmol       Date:  1995-12
View more
  13 in total

1.  The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.

Authors:  J S Mohan; P L Lip; A D Blann; D Bareford; G Y H Lip
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

Review 2.  New Ways to Detect Pediatric Sickle Cell Retinopathy: A Comprehensive Review.

Authors:  Daniel A Pahl; Nancy S Green; Monica Bhatia; Royce W S Chen
Journal:  J Pediatr Hematol Oncol       Date:  2017-11       Impact factor: 1.289

3.  Neutrophils and leucocyte adhesion molecules in sickle cell retinopathy.

Authors:  M Kunz Mathews; D S McLeod; C Merges; J Cao; G A Lutty
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

4.  Effect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog.

Authors:  Gerard A Lutty; D Scott McLeod; Imran Bhutto; Stanley J Wiegand
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-08       Impact factor: 4.799

Review 5.  The past, present and future management of sickle cell retinopathy within an African context.

Authors:  Kwesi Nyan Amissah-Arthur; Evelyn Mensah
Journal:  Eye (Lond)       Date:  2018-07-10       Impact factor: 3.775

6.  Monitoring retinal pathology and cerebral injury in sickle cell disease using spectral-domain optical coherence tomography in pediatric patients.

Authors:  Jing Jin; Vinay Kandula; Robin E Miller
Journal:  Pediatr Blood Cancer       Date:  2021-03-31       Impact factor: 3.838

7.  [Fortuitous detection of composite heterozygous S/C sickle cell disease].

Authors:  Asmâa Biaz; Maroua Neji; Yousra Ajhoun; Samira El Machtani Idrissi; Abdellah Dami; Karim Reda; Zohra Ouzzif; Sanae Bouhsain
Journal:  Pan Afr Med J       Date:  2017-06-07

8.  Peripheral sea-fan retinal neovascularization as a manifestation of chronic rhegmatogenous retinal detachment and surgical management.

Authors:  Ilias Georgalas; Theodore Paraskevopoulos; Chyssanthos Symmeonidis; Petros Petrou; Chryssanthi Koutsandrea
Journal:  BMC Ophthalmol       Date:  2014-09-23       Impact factor: 2.209

9.  Expression Pattern of HIF-1α and VEGF Supports Circumferential Application of Scatter Laser for Proliferative Sickle Retinopathy.

Authors:  Murilo Rodrigues; Fabiana Kashiwabuchi; Monika Deshpande; Kathleen Jee; Morton F Goldberg; Gerard Lutty; Gregg L Semenza; Silvia Montaner; Akrit Sodhi
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-12-01       Impact factor: 4.799

10.  Ocular Histopathology and Immunohistochemical Analysis in the Oldest Known Individual with Autosomal Dominant Vitreoretinochoroidopathy.

Authors:  Morton F Goldberg; Scott McLeod; Mark Tso; Kirk Packo; Malia Edwards; Imran A Bhutto; Rajkumar Baldeosingh; Charles Eberhart; Bernhard H F Weber; Gerard A Lutty
Journal:  Ophthalmol Retina       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.